Join to View Full Profile
200 1st St SwRochester, MN 55905
Phone+1 507-284-2511
Dr. Thanarajasingam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2012 - 2016
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2008 - 2011- Mayo Clinic College of MedicineClass of 2008
Certifications & Licensure
MN State Medical License 2012 - 2025
MA State Medical License 2010 - 2013
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- SOHO State of the Art Updates and Next Questions | Measuring Patient-Reported Outcomes (PROs) and Treatment Tolerability in Patients With Hematologic Malignancies.Ajay Major, Amylou C Dueck, Gita Thanarajasingam
Clinical Lymphoma, Myeloma & Leukemia. 2025-03-01 - Comparison of outcomes in postinduction strategies for primary central nervous system lymphoma: a Mayo Clinic experience.Steven R Hwang, Richard C Godby, Brianna J Negaard, Raphael Mwangi, Adrienne N Nedved
Blood Advances. 2025-02-25 - 1 citationsSymptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trial.Ethan Basch, Deborah Schrag, Jennifer Jansen, Sydney Henson, Brenda Ginos
Nature Medicine. 2025-02-07
Abstracts/Posters
- A Phase II Study of Nivolumab in Patients with Relapsed or Refractory Peripheral T-Cell LymphomaGita Thanarajasingam, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Patient Experience of Chimeric Antigen Receptor (CAR)-T Cell Therapy Vs. Stem Cell Transplant: Longitudinal Patient Reported Adverse Events, Cognition and Quality of LifeGita Thanarajasingam, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Treatment and Lifestyle Risk Factors for Cardiovascular Disease Post Lymphoma Diagnosis: A Prospective Study in the Modern Treatment EraGita Thanarajasingam, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
First Walk on! In Memory of Chuck Papanos Is Set for July 30July 6th, 2021- Predictors of Short-Term Survival in Waldenström MacroglobulinemiaJuly 14th, 2020
Novel Metric Sheds Light on When Adverse Events May OccurJune 6th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
